Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) - United States, October 2017-June 2018

Published on January 31, 2019

Early recombinant zoster vaccine safety monitoring findings are consistent with prelicensure clinical trial data. Serious adverse events were rare, and no unexpected patterns were detected.

Other news

Characteristics of Deceased Solid Organ Donors and Screening Results for Hepatitis B, C, and Human Immunodeficiency Viruses - United States, 2010-2017

January 24, 2019
The number and proportion of increased risk donors have increased since 2010, likely because of the epidemic of opioid overdose deaths. Compared with standard risk donors, increased risk donors were significantly more likely to have hepatitis B virus and hepatitis C virus infection.

Awareness of Heart Attack Symptoms and Response Among Adults --- United States, 2008, 2014, and 2017

February 7, 2019
Analysis of National Health Interview Survey data for 2008, 2014, and 2017 found that knowledge of the five common symptoms of a heart attack and the appropriate emergency response increased significantly (from 40% to 50% and from 92% to 95%, respectively); however, sociodemographic disparities in knowledge persist.